MBX Biosciences, Inc. (MBX) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $369.22M | +43.4% |
| 2024 | $257.44M | +455.2% |
| 2023 | -$72.47M | -70.1% |
| 2022 | -$42.60M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $369.22M | +43.4% |
| 2024 | $257.44M | +455.2% |
| 2023 | -$72.47M | -70.1% |
| 2022 | -$42.60M | — |